title: [Blood level of lipid peroxidation products as an indicator of resistance to infectious inflammatory complications of transurethral electroresection of the prostate].
abstract: Study of relationship between the content of lipid peroxidation (LPO) products in the blood of patients with benign prostatic hyperplasia (BPH) and resistance to infectious inflammatory complications (IIC) of transurethral electroresection of the prostate showed that decreased content of circulating lipoperoxides promoted the development of postoperative IIC. Before the operation blood levels of LPO products were increased in BPH patients who did not develop IIC postoperation in comparison with normal controls. Three intravenous injections of ascorbic acid in a single dose of 1000 mg after transurethral electroresection of the prostate led to an increase in the blood level of LPO products and promoted a decrease in the incidence of postoperative IIC.
authors.forename: I A
authors.initials: IA
authors.lastname: Volchegorskiĭ
authors.forename: V F
authors.initials: VF
authors.lastname: Sharapov
authors.forename: A Iu
authors.initials: AIu
authors.lastname: Vasil'kov
authors.forename: A N
authors.initials: AN
authors.lastname: Popov
mesh_terms: D000975:Antioxidants / Q000008:administration & dosage; D001205:Ascorbic Acid / Q000008:administration & dosage; D001424:Bacterial Infections / Q000097:blood / Q000175:diagnosis* / Q000517:prevention & control; D015415:Biomarkers; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000175:diagnosis* / Q000517:prevention & control; D007275:Injections, Intravenous; D015227:Lipid Peroxidation; D008297:Male; D011183:Postoperative Complications / Q000097:blood / Q000175:diagnosis* / Q000517:prevention & control; D011470:Prostatic Hyperplasia / Q000601:surgery*; D020728:Transurethral Resection of Prostate / Q000009:adverse effects*
chemical_list: D000975:Antioxidants; D015415:Biomarkers; D001205:Ascorbic Acid